BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22749235)

  • 1. Interferon signaling in the liver during hepatitis C virus infection.
    Makowska Z; Heim MH
    Cytokine; 2012 Sep; 59(3):460-6. PubMed ID: 22749235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Type III Interferons in Hepatitis C Virus Infection and Therapy.
    Bruening J; Weigel B; Gerold G
    J Immunol Res; 2017; 2017():7232361. PubMed ID: 28255563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subversion of innate host antiviral strategies by the hepatitis C virus.
    Bode JG; Brenndörfer ED; Häussinger D
    Arch Biochem Biophys; 2007 Jun; 462(2):254-65. PubMed ID: 17467654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of interferon and ribavirin in treatment of hepatitis C.
    Feld JJ; Hoofnagle JH
    Nature; 2005 Aug; 436(7053):967-72. PubMed ID: 16107837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.
    Howell J; Angus P; Gow P; Visvanathan K
    J Gastroenterol Hepatol; 2013 May; 28(5):766-76. PubMed ID: 23432473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
    Thimme R; Lohmann V; Weber F
    Antiviral Res; 2006 Mar; 69(3):129-41. PubMed ID: 16413618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evasion of intracellular host defence by hepatitis C virus.
    Gale M; Foy EM
    Nature; 2005 Aug; 436(7053):939-45. PubMed ID: 16107833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organ system view of the hepatic innate immunity in HCV infection.
    Bang BR; Elmasry S; Saito T
    J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic innate immunity by hepatitis C virus.
    Horner SM; Gale M
    Nat Med; 2013 Jul; 19(7):879-88. PubMed ID: 23836238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
    Bode JG; Brenndörfer ED; Häussinger D
    Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Interferon Alpha Receptor 2 in Interferon Resistant HCV Patients.
    Trali GA; Naveed AK; Rasheed A; Bashir Q; Khan RS; Majeed A; Razak S
    Hepatogastroenterology; 2014 May; 61(131):752-4. PubMed ID: 26176069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
    Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
    Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population.
    Main J
    J Hepatol; 1995; 23 Suppl 2():32-5; discussion 35-6. PubMed ID: 8720292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of hepatitis C virus with the type I interferon system.
    Weber F
    World J Gastroenterol; 2007 Sep; 13(36):4818-23. PubMed ID: 17828812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and evasion of innate antiviral responses by hepatitis C virus.
    Lemon SM
    J Biol Chem; 2010 Jul; 285(30):22741-7. PubMed ID: 20457596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liver-cytokine-brain circuit in interferon-based treatment of patients with chronic viral hepatitis.
    Stasi C; Zignego AL; Laffi G; Rosselli M
    J Viral Hepat; 2011 Aug; 18(8):525-32. PubMed ID: 21762284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells and hepatitis C: action and reaction.
    Cheent K; Khakoo SI
    Gut; 2011 Feb; 60(2):268-78. PubMed ID: 20876777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.